Vikas Lifecare Cleared in SEBI Adjudication Order with No Penalties Imposed

Vikas Lifecare Limited has received a favorable outcome from the Securities and Exchange Board of India (SEBI) regarding a regulatory matter that had been under examination. The company announced on December 20 that SEBI's adjudication order has cleared it of any adverse findings or penalties.

SEBI Adjudication Order Details

SEBI issued Adjudication Order No. Order/AK/GN/2025-26/31848-31890 on December 19, following a detailed examination of facts, submissions, and documents on record. The order pertains to certain trading transactions in equity shares of another BSE-listed company that were undertaken by the company, its promoter, and certain associated persons.

Parameter	Details
Order Number	Order/AK/GN/2025-26/31848-31890
Order Date	December 19
Nature of Matter	Trading transactions in equity shares of another BSE-listed company
Parties Involved	Company, its promoter, and certain associated persons
Outcome	No adverse findings, directions, or penalties imposed

Background and Timeline

The regulatory scrutiny began with a Show Cause Notice (SCN) dated February 13, which was issued by SEBI and announced by the company on February 17. The notice named the company, its promoter, and certain associated persons as noticees in relation to the trading transactions under examination.

Company's Response to Misleading Communications

Vikas Lifecare highlighted that certain persons with apparent malafide intent had circulated unauthorized and misleading communications relating to the original show cause notice. These communications selectively emphasized the issuance of the SCN while ignoring its factual outcome, falsely suggesting that the company was under scrutiny concerning its businesses and governance matters.

The company stated that such misrepresentations appeared intended to:

Damage the company's reputation
Mislead investors
Influence public perception negatively

Impact Assessment

According to the regulatory disclosure, there is no impact on the company's financials, operations, or other activities. This assessment is based on the fact that no adverse findings, directions, or penalties have been imposed on the company, its promoter, or associated persons.

Impact Category	Assessment
Financial Impact	No impact
Operational Impact	No impact
Other Activities	No impact
Reason	No adverse findings or penalties imposed

Stakeholder Advisory

The company strongly urged all stakeholders to disregard any unverified or unauthorized communications and rely solely on official disclosures for accurate and complete information. The SEBI adjudication order is available on the SEBI website for public reference, providing transparency regarding the regulatory outcome.

This favorable resolution represents a significant development for Vikas Lifecare, as it conclusively addresses the regulatory matter that had been pending and confirms the company's compliance with applicable regulations.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.09%	+1.65%	+1.09%	-27.45%	-57.67%	-63.29%

Vikas Lifecare Limited has announced a significant change to its board composition. The company's Board of Directors has recommended the appointment of Mr. Shri Pal Goel as an Independent Director for a five-year term, subject to shareholder approval at the upcoming Annual General Meeting (AGM).

Appointment Details

The recommendation comes following a proposal from a company member and subsequent approval by the Nomination and Remuneration Committee. Mr. Goel, who holds Director Identification Number (DIN) 07352580, is set to begin his tenure on September 29, 2025, pending shareholder approval at the 30th AGM scheduled for the same date.

About Shri Pal Goel

Mr. Goel brings a wealth of experience to the table:

Educational Background: MA in Economics from Kurukshetra University (Gold Medalist)
Professional Experience: Over 35 years in the banking sector
Career Highlight: Retired as General Manager of North Zone at Union Bank of India
Expertise: Extensive experience across retail banking, treasury, and risk management departments
Achievements: Recipient of best business performance awards in 2003, 2006, and 2009

Current Roles and Responsibilities

Mr. Goel currently serves as an Independent Director at Delphi World Money Limited. He also holds positions with various charitable organizations, including:

Vice-Chairman (Finance & Treasury) for Maharaja Agrasen Institute of Technology Delhi
Trustee & Fund Manager with Maharaja Agrasen Hospital
Trustee with Balaji Nirogdham (Delhi)
Involvement with charitable organizations in Ayodhya & Salasar

Appointment Process and Compliance

The company has emphasized its commitment to regulatory compliance:

The appointment recommendation follows the receipt of a notice from a member under Section 160 of the Companies Act, 2013.
An addendum to the AGM notice will be circulated to shareholders, incorporating the recommendation for their approval.
Vikas Lifecare has confirmed that Mr. Goel is not debarred from holding the office of Director by the Securities and Exchange Board of India (SEBI) or any other authority.

Impact on Corporate Governance

The potential appointment of Mr. Shri Pal Goel as an Independent Director aligns with Vikas Lifecare's commitment to strong corporate governance. His extensive experience in the banking sector, particularly in areas such as risk management and fund management, is expected to bring valuable insights to the company's board.

Shareholders will have the opportunity to vote on this appointment at the upcoming AGM, marking a significant step in shaping the future leadership of Vikas Lifecare Limited.